{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:10:56Z","timestamp":1793232656835,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:00:00Z","timestamp":1718755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Beijing Hospitals Authority Youth Programme","award":["QML20231105"],"award-info":[{"award-number":["QML20231105"]}]},{"name":"Xisike-leader Oncology Research Foundation","award":["Y-2019AZZD-0369"],"award-info":[{"award-number":["Y-2019AZZD-0369"]}]},{"name":"Beijing Bethune Charitable Foundation","award":["mnzl202003"],"award-info":[{"award-number":["mnzl202003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Basement membrane (BM) is an important component of the extracellular matrix, which plays an important role in the growth and metastasis of tumor cells. However, few biomarkers based on BM have been developed for prognostic assessment and prediction of immunotherapy in bladder cancer (BLCA).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this study, we used the BLCA public database to explore the relationship between BM-related genes (BMRGs) and prognosis. A novel molecular typing of BLCA was performed using consensus clustering. LASSO regression was used to construct a signature based on BMRGs, and its relationship with prognosis was explored using survival analysis. The pivotal BMRGs were further analyzed to assess its clinical characteristics and immune landscape. Finally, immunohistochemistry was used to detect the expression of the hub gene in BLCA patients who underwent surgery or received immune checkpoint inhibitor (ICI) immunotherapy in our hospital.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We comprehensively analyzed the relationship between BMRGs and BLCA, and established a prognostic-related signature which was an independent influence on the prognostic prediction of BLCA. We further screened and validated the pivotal gene-MMP14 in public database. In addition, we found that MMP14 expression in muscle invasive bladder cancer (MIBC) was significantly higher and high MMP14 expression had a poorer response to ICI treatment in our cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our findings highlighted the satisfactory value of BMRGs and suggested that MMP14 may be a potential biomarker in predicting prognosis and response to immunotherapy in BLCA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-024-12489-y","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T04:01:46Z","timestamp":1718769706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Xuezhou","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingchuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,19]]},"reference":[{"issue":"1","key":"12489_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"12489_CR2","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD. Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin. 2020;70(5):404\u201323.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12489_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.juro.2016.02.3005","volume":"197","author":"NM Donin","year":"2017","unstructured":"Donin NM, Lenis AT, Holden S, et al. Immunotherapy for the Treatment of Urothelial Carcinoma. J Urol. 2017;197(1):14\u201322.","journal-title":"J Urol"},{"key":"12489_CR4","doi-asserted-by":"crossref","unstructured":"Konala VM, Adapa S, Aronow WS. Immunotherapy in bladder Cancer. Am J Ther 2022 May-Jun 01;29(3):e334\u20137.","DOI":"10.1097\/MJT.0000000000000934"},{"issue":"5","key":"12489_CR5","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00345-020-03474-8","volume":"39","author":"JL Pfail","year":"2021","unstructured":"Pfail JL, Katims AB, Alerasool P, et al. Immunotherapy in non-muscle-invasive bladder cancer: current status and future directions. World J Urol. 2021;39(5):1319\u201329.","journal-title":"World J Urol"},{"key":"12489_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.matbio.2016.12.009","volume":"57\u201358","author":"A Pozzi","year":"2017","unstructured":"Pozzi A, Yurchenco PD, Iozzo RV. The nature and biology of basement membranes. Matrix Biol. 2017;57\u201358:1\u201311.","journal-title":"Matrix Biol"},{"issue":"3","key":"12489_CR7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.gendis.2021.03.004","volume":"9","author":"S Zhou","year":"2021","unstructured":"Zhou S, Chen S, Pei YA, et al. Nidogen: a matrix protein with potential roles in musculoskeletal tissue regeneration. Genes Dis. 2021;9(3):598\u2013609.","journal-title":"Genes Dis"},{"issue":"5","key":"12489_CR8","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.81939","volume":"19","author":"W Tian","year":"2023","unstructured":"Tian W, Luo Y, Tang Y, et al. Novel implication of the basement membrane for breast Cancer Outcome and Immune Infiltration. Int J Biol Sci. 2023;19(5):1645\u201363.","journal-title":"Int J Biol Sci"},{"issue":"6","key":"12489_CR9","doi-asserted-by":"publisher","first-page":"10694","DOI":"10.3934\/mbe.2023474","volume":"20","author":"Y Xi","year":"2023","unstructured":"Xi Y, Song L, Wang S, et al. Identification of basement membrane-related prognostic signature for predicting prognosis, immune response and potential drug prediction in papillary renal cell carcinoma. Math Biosci Eng. 2023;20(6):10694\u2013724.","journal-title":"Math Biosci Eng"},{"issue":"9","key":"12489_CR10","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.7150\/jca.83407","volume":"14","author":"H Shi","year":"2023","unstructured":"Shi H, Sun L, Liu B. Comprehensive analysis of the basement membrane in lung adenocarcinoma by bulk and single-cell sequencing analysis. J Cancer. 2023;14(9):1635\u201347.","journal-title":"J Cancer"},{"issue":"10031","key":"12489_CR11","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/S0140-6736(16)00561-4","volume":"387","author":"JE Rosenberg","year":"2016","unstructured":"Rosenberg JE, Hoffman-Censits J, Powles T, et al. Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial. Lancet. 2016;387(10031):1909\u201320.","journal-title":"Lancet"},{"issue":"21","key":"12489_CR12","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, et al. TIMER: a web server for Comprehensive Analysis of Tumor-infiltrating Immune cells. Cancer Res. 2017;77(21):e108\u201310.","journal-title":"Cancer Res"},{"key":"12489_CR13","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1472-6947-8-53","volume":"8","author":"AJ Vickers","year":"2008","unstructured":"Vickers AJ, Cronin AM, Elkin EB, et al. Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers. BMC Med Inf Decis Mak. 2008;8:53.","journal-title":"BMC Med Inf Decis Mak"},{"issue":"Suppl 4","key":"12489_CR14","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, et al. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11.","journal-title":"BMC Syst Biol"},{"issue":"1","key":"12489_CR15","doi-asserted-by":"publisher","first-page":"bbac558","DOI":"10.1093\/bib\/bbac558","volume":"24","author":"CJ Liu","year":"2023","unstructured":"Liu CJ, Hu FF, Xie GY, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023;24(1):bbac558.","journal-title":"Brief Bioinform"},{"issue":"1","key":"12489_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"11","key":"12489_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.annonc.2022.07.011","volume":"33","author":"R Iacovelli","year":"2022","unstructured":"Iacovelli R, Ciccarese C, Brunelli M, et al. First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin. Ann Oncol. 2022;33(11):1179\u201385.","journal-title":"Ann Oncol"},{"issue":"5","key":"12489_CR18","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.annonc.2021.02.006","volume":"32","author":"DJ McGrail","year":"2021","unstructured":"McGrail DJ, Pili\u00e9 PG, Rashid NU, et al. High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types. Ann Oncol. 2021;32(5):661\u201372.","journal-title":"Ann Oncol"},{"issue":"6","key":"12489_CR19","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1016\/j.cub.2017.02.006","volume":"27","author":"R Jayadev","year":"2017","unstructured":"Jayadev R, Sherwood DR. Basement membranes. Curr Biol. 2017;27(6):R207\u201311.","journal-title":"Curr Biol"},{"issue":"6","key":"12489_CR20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41563-020-00894-0","volume":"20","author":"R Reuten","year":"2021","unstructured":"Reuten R, Zendehroud S, Nicolau M, et al. Basement membrane stiffness determines metastases formation. Nat Mater. 2021;20(6):892\u2013903.","journal-title":"Nat Mater"},{"issue":"2","key":"12489_CR21","doi-asserted-by":"publisher","first-page":"151220","DOI":"10.1016\/j.ejcb.2022.151220","volume":"101","author":"S Banerjee","year":"2022","unstructured":"Banerjee S, Lo WC, Majumder P, et al. Multiple roles for basement membrane proteins in cancer progression and EMT. Eur J Cell Biol. 2022;101(2):151220.","journal-title":"Eur J Cell Biol"},{"issue":"6","key":"12489_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/ncb2743","volume":"15","author":"K Zhang","year":"2013","unstructured":"Zhang K, Corsa CA, Ponik SM, et al. The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis. Nat Cell Biol. 2013;15(6):677\u201387.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"12489_CR23","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3390\/biom11020336","volume":"11","author":"R Melchionna","year":"2021","unstructured":"Melchionna R, Trono P, Tocci A, et al. Actin cytoskeleton and regulation of TGF\u03b2 signaling: exploring their links. Biomolecules. 2021;11(2):336.","journal-title":"Biomolecules"},{"issue":"20","key":"12489_CR24","doi-asserted-by":"publisher","first-page":"jcs244848","DOI":"10.1242\/jcs.244848","volume":"133","author":"OY Revach","year":"2020","unstructured":"Revach OY, Grosheva I, Geiger B. Biomechanical regulation of focal adhesion and invadopodia formation. J Cell Sci. 2020;133(20):jcs244848.","journal-title":"J Cell Sci"},{"issue":"10","key":"12489_CR25","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3390\/cancers15102701","volume":"15","author":"D Koca","year":"2023","unstructured":"Koca D, S\u00e9raudie I, Jardillier R, et al. COL7A1 expression improves prognosis prediction for patients with Clear Cell Renal Cell Carcinoma atop of stage. Cancers (Basel). 2023;15(10):2701.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"12489_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1049\/syb2.12067","volume":"17","author":"Z Lu","year":"2023","unstructured":"Lu Z, Lu Z, Lai Y, et al. A comprehensive analysis of FBN2 in bladder cancer: a risk factor and the tumour microenvironment influencer. IET Syst Biol. 2023;17(4):162\u201373.","journal-title":"IET Syst Biol"},{"issue":"3","key":"12489_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3892\/ol.2023.13968","volume":"26","author":"A Grossauer","year":"2023","unstructured":"Grossauer A, Uranowska K, Kitzw\u00f6gerer M, et al. Immunohistochemical detection of the chondroitin sulfate proteoglycan 4 protein in primary and metastatic melanoma. Oncol Lett. 2023;26(3):382.","journal-title":"Oncol Lett"},{"key":"12489_CR28","doi-asserted-by":"publisher","first-page":"111355","DOI":"10.1016\/j.biopha.2021.111355","volume":"138","author":"H Xing","year":"2021","unstructured":"Xing H, Wang P, Liu S, et al. A global integrated analysis of UNC5C down-regulation in cancers: insights from mechanism and combined treatment strategy. Biomed Pharmacother. 2021;138:111355.","journal-title":"Biomed Pharmacother"},{"issue":"7","key":"12489_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1091\/mbc.E20-01-0060","volume":"32","author":"LR Decotret","year":"2021","unstructured":"Decotret LR, Wadsworth BJ, Li LV, et al. Receptor-type protein tyrosine phosphatase alpha (PTP\u03b1) mediates MMP14 localization and facilitates triple-negative breast cancer cell invasion. Mol Biol Cell. 2021;32(7):567\u201378.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"12489_CR30","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.pathol.2020.01.436","volume":"52","author":"Y Jin","year":"2020","unstructured":"Jin Y, Liang ZY, Zhou WX, et al. High MMP14 expression is predictive of poor prognosis in resectable hepatocellular carcinoma. Pathology. 2020;52(3):359\u201365.","journal-title":"Pathology"},{"issue":"5","key":"12489_CR31","doi-asserted-by":"publisher","first-page":"5921","DOI":"10.3934\/mbe.2021296","volume":"18","author":"Y Li","year":"2021","unstructured":"Li Y, Su Z, Wei B, et al. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis. Math Biosci Eng. 2021;18(5):5921\u201342.","journal-title":"Math Biosci Eng"},{"issue":"3","key":"12489_CR32","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1172\/JCI135239","volume":"130","author":"L Claesson-Welsh","year":"2020","unstructured":"Claesson-Welsh L. How the matrix metalloproteinase MMP14 contributes to the progression of colorectal cancer. J Clin Invest. 2020;130(3):1093\u20135.","journal-title":"J Clin Invest"},{"issue":"19","key":"12489_CR33","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.3748\/wjg.v29.i19.2961","volume":"29","author":"J Wu","year":"2023","unstructured":"Wu J, Guo Y, Zuo ZF, et al. MMP14 is a diagnostic gene of intrahepatic cholangiocarcinoma associated with immune cell infiltration. World J Gastroenterol. 2023;29(19):2961\u201378.","journal-title":"World J Gastroenterol"},{"key":"12489_CR34","doi-asserted-by":"publisher","first-page":"115540","DOI":"10.1016\/j.bcp.2023.115540","volume":"211","author":"WC Chen","year":"2023","unstructured":"Chen WC, Chang AC, Tsai HC, et al. Bone sialoprotein promotes lung cancer osteolytic bone metastasis via MMP14-dependent mechanisms. Biochem Pharmacol. 2023;211:115540.","journal-title":"Biochem Pharmacol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-12489-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-12489-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T19:04:33Z","timestamp":1718823873000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-12489-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["12489"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-12489-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,19]]},"assertion":[{"value":"2 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of Peking University Cancer Hospital (Institutional Review Board approval number, 2020KT143-GZ01). Participants provided informed consent. This study is adhered to the ethical guidelines of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"746"}}